Page last updated: 2024-11-05

trimethoprim and Retinal Degeneration

trimethoprim has been researched along with Retinal Degeneration in 1 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)

Research Excerpts

ExcerptRelevanceReference
"Retinal degenerations are a large cluster of diseases characterized by the irreversible loss of light-sensitive photoreceptors that impairs the vision of 9."1.48A Drug-Tunable Gene Therapy for Broad-Spectrum Protection against Retinal Degeneration. ( Ash, JD; Boye, SE; Boye, SL; Imam, AA; Keuthan, CJ; Santiago, CP, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santiago, CP1
Keuthan, CJ1
Boye, SL1
Boye, SE1
Imam, AA1
Ash, JD1

Other Studies

1 other study available for trimethoprim and Retinal Degeneration

ArticleYear
A Drug-Tunable Gene Therapy for Broad-Spectrum Protection against Retinal Degeneration.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2018, 10-03, Volume: 26, Issue:10

    Topics: Animals; Dependovirus; Gene Expression Regulation; Genetic Therapy; Humans; Leukemia Inhibitory Fact

2018